Eculizumab

• Description:

  Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  148 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets

• CAS Number:

  219685-50-4